The assessment of antimalarial drug efficacy.
暂无分享,去创建一个
[1] M. Bangs,et al. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia , 2002, The Lancet.
[2] L. Aarons,et al. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection , 2002, Parasitology.
[3] R. Snow,et al. The past, present and future of childhood malaria mortality in Africa. , 2001, Trends in parasitology.
[4] P. Newton,et al. Contribution of humoral immunity to the therapeutic response in falciparum malaria. , 2001, The American journal of tropical medicine and hygiene.
[5] J. M. Rubio,et al. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[6] Leon Aarons,et al. Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[7] C. Newbold,et al. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. , 2000, The Journal of infectious diseases.
[8] J. Simpson,et al. Therapeutic Responses to Different Antimalarial Drugs in Vivax Malaria , 2000, Antimicrobial Agents and Chemotherapy.
[9] S. Heisterkamp,et al. Combinations of Artemisinin and Quinine for Uncomplicated Falciparum Malaria: Efficacy and Pharmacodynamics , 2000, Antimicrobial Agents and Chemotherapy.
[10] N. White,et al. Editorial: Antimalarial drug resistance and mortality in falciparum malaria , 1999, Tropical medicine & international health : TM & IH.
[11] N. White. Antimalarial drug resistance and mortality in falciparum malaria [editorial] , 1999 .
[12] R. Snow,et al. Averting a malaria disaster , 1999, The Lancet.
[13] N. White,et al. Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[14] Baird Jk. Primaquine as anti-relapse therapy for Plasmodium vivax. , 1998 .
[15] J. Baird,et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. , 1998, The American journal of tropical medicine and hygiene.
[16] K. Marsh. Malaria disaster in Africa , 1998, The Lancet.
[17] N. White,et al. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo , 1997, Antimicrobial agents and chemotherapy.
[18] Suradi,et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. , 1997, The American journal of tropical medicine and hygiene.
[19] N. White,et al. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. , 1996, Blood.
[20] J. Baird,et al. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[21] S. Pukrittayakamee,et al. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. , 1994, The Journal of infectious diseases.
[22] F. Smithuis,et al. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border , 1993, Antimicrobial Agents and Chemotherapy.
[23] F. T. Ter Kuile,et al. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. , 1993, Experimental parasitology.
[24] D. Kwiatkowski,et al. OPEN COMPARISON OF INTRAMUSCULAR CHLOROQUINE AND QUININE IN CHILDREN WITH SEVERE CHLOROQUINE-SENSITIVE FALCIPARUM MALARIA , 1989, The Lancet.
[25] N. White,et al. Treatment of malaria: some considerations and limitations of the current methods of assessment. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[26] P. Garnham. Malaria Parasites and Other Haemosporidia , 1966 .
[27] W. Yorke,et al. Observations on malaria made during treatment of general paralysis , 1924 .
[28] J. Trape. The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.
[29] P. Bloland,et al. Monitoring antimalarial drug resistance (report of a WHO Consultation) , 2001 .
[30] F. Nosten,et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. , 1999, The American journal of tropical medicine and hygiene.
[31] J. Baird. Primaquine as anti-relapse therapy for Plasmodium vivax. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[32] W. Jarra,et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. , 1995, Bulletin of the World Health Organization.
[33] W. Wernsdorfer,et al. Chemotherapy of malaria , 1981 .
[34] Resistance to Antimalarials. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. , 1973, World Health Organization technical report series.
[35] D. G. Davey. Chemotherapy of malaria. , 1951, British medical bulletin.